Protocol to assess the efficacy of carnosine supplementation in mitigating the adverse cardiovascular responses to particulate matter (PM) exposure: the Nucleophilic Defense Against PM Toxicity (NEAT) trial.
Timothy E O'TooleAlok A AmraotkarAndrew P DeFilippisShesh N RaiRachel J KeithShahid P BabaPawel LorkiewiczCatherine E CrandellGina L PariserChristopher J WingardC Arden Pope IiiAruni BhatnagarPublished in: BMJ open (2020)
This study protocol has been approved by the Institutional Review Board at the University of Louisville. Results from this study will be disseminated at scientific conferences and in peer-reviewed publications.Trial registration: NCT03314987; Pre-results.